Funding
Growth · Biotech

Celea Therapeutics receives $180M growth financing

Celea Therapeutics received $180 million in growth financing announced in July.

Updated Oct 16, 2026By RoundOS Funding desk

RA Capital Management, Leaps by Bayer and PureTech Health are among its backers. The company develops treatments for serious respiratory diseases.

Funding history

Growth · This round$180M

Sources

  1. Celea Therapeuticsprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related